Cited 6 times in
Combination of docetaxel and TSU-68, an oral antiangiogenic agent, in patients with metastatic breast cancer previously treated with anthracycline: Randomized phase II multicenter trial
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.